Montreal’s Inocucor Technologies Inc., the agriculture biotech company that produces biological accelerators for farmers, receives a notice of allowance from the U.S. Patent and Trademark Office for its patent application to protect Inocucor consortia and unique microbial products that accelerate plant growth and enhance yields on farms and in greenhouses._x000D_
_x000D_
This initial patent relates to Inocucor’s live IN-M1 microbial consortium and its fermentation byproducts, which are the basis of the formulation for Inocucor Garden Solution, the company’s first-generation growth-accelerator product. Garden Solution is formulated to naturally sustain robust plant growth, increase plant vigor and actively build a friable and rich soil, improving the health of the entire phyto-microbiome._x000D_
_x000D_
The patent applies to each of the individual Inocul-M microorganisms characterized by Inocucor and in other task-specific live consortia like IN-M1. Also protected are the biological ingredients produced during Inocucor’s multi-species manufacturing process._x000D_
_x000D_
“Inocucor pioneered this proprietary fermentation process that combines natural bacteria and yeasts into powerful living growth stimulants for soil, seeds and plants,” says Margaret Bywater-Ekegärd, co-founder and executive vice president of technology and innovation at Inocucor. “It is the first of numerous patents we expect to be granted for our unique approach to processes and products for bio-stimulation, bio-fertility and bio-protection.”_x000D_
_x000D_
_x000D_
_x000D_
Inocucor recently opened a new headquarters and lab in Montreal’s bioscience corridor that is compliant with current Good Manufacturing Practices (cGMPs) for the food industry. It has attracted collaborators from both the private and academic sectors in Canada and the U.S._x000D_
_x000D_
